Classical Hodgkin lymphoma and CD30+diffuse large B-cell lymphoma: Opposite ends of a clinical and immunophenotypic spectrum?

被引：0
|
作者：
Teasdale, J [1 ]
Barrans, SL [1 ]
Maclennan, KA [1 ]
Owen, RG [1 ]
Jack, A [1 ]
机构：
[1] Gen Infirm, HMDS, Acad Unit Haematol & Oncol, Leeds LS1 3EX, W Yorkshire, England
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1340
引用
收藏
页码：346A / 346A
页数：1
相关论文
共 50 条
  • [1] Composite lymphoma associating diffuse large B-cell lymphoma with classical Hodgkin lymphoma
    Lauwers, Mailis
    Daubie, Valery
    Farhat, Hussein
    Rocq, Laureen
    Trepant, Anne-Laure
    Vanoverschelde, Laura
    EJHAEM, 2022, 3 (04): : 1409 - 1411
  • [2] Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma
    Bakshi, Nasir A.
    Finn, William G.
    Schnitzer, Bertram
    Valdez, Riccardo
    Ross, Charles W.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2007, 131 (05) : 742 - 747
  • [3] Molecular heterogeneity of CD30+diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
    Huo, Yu-Jia
    Xu, Peng-Peng
    Fu, Di
    Yi, Hong-Mei
    Huang, Yao-Hui
    Wang, Li
    Wang, Nan
    Ji, Meng-Meng
    Liu, Qing-Xiao
    Shi, Qing
    Wang, Shuo
    Cheng, Shu
    Feng, Yan
    Zhao, Wei-Li
    BLOOD CANCER JOURNAL, 2022, 12 (03)
  • [4] Sinusoidal CD30+diffuse large B-cell lymphoma can masquerade as anaplastic large cell lymphoma in pediatric posttransplant lymphoproliferative disorders
    Bhatt, Neel S.
    Kelly, Michael E.
    Batdorf, Bjorn
    Gheorghe, Gabriela
    PEDIATRIC BLOOD & CANCER, 2017, 64 (08)
  • [5] Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma
    Shinichi Makita
    Akiko Miyagi Maeshima
    Hirokazu Taniguchi
    Hideaki Kitahara
    Suguru Fukuhara
    Wataru Munakata
    Tatsuya Suzuki
    Dai Maruyama
    Yukio Kobayashi
    Kensei Tobinai
    International Journal of Hematology, 2016, 104 : 396 - 399
  • [6] The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases
    Gualco, Gabriela
    Natkunam, Yasodha
    Bacchi, Carlos E.
    MODERN PATHOLOGY, 2012, 25 (05) : 661 - 674
  • [7] Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma
    Makita, Shinichi
    Maeshima, Akiko Miyagi
    Taniguchi, Hirokazu
    Kitahara, Hideaki
    Fukuhara, Suguru
    Munakata, Wataru
    Suzuki, Tatsuya
    Maruyama, Dai
    Kobayashi, Yukio
    Tobinai, Kensei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (03) : 396 - 399
  • [8] Hodgkin Lymphoma Following Diffuse Large B-Cell Lymphoma: A Clinical and Pathologic Review
    Sethi, Shenon
    Miller, Ira
    MODERN PATHOLOGY, 2019, 32
  • [9] Hodgkin Lymphoma Following Diffuse Large B-Cell Lymphoma: A Clinical and Pathologic Review
    Sethi, Shenon
    Miller, Ira
    LABORATORY INVESTIGATION, 2019, 99
  • [10] B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma
    Noriko Iwaki
    Yasuharu Sato
    Toshiro Kurokawa
    Yoshinobu Maeda
    Kyotaro Ohno
    Mai Takeuchi
    Katsuyoshi Takata
    Yorihisa Orita
    Shinji Nakao
    Tadashi Yoshino
    Medical Molecular Morphology, 2013, 46 : 172 - 176
12345